Clik here to view.
Medidata 积极推动临床试验多样性，支持超过3万项试验和900万名试验参与者
纽约 以临床试验领域的突破性创新而闻名的达索系统(Dassault Systèmes) 旗下公司Medidata近日宣布，其平台运行的临床试验已突破3万项，参与者人数超过900万名。这两项里程碑由Medidata携手2,100多家全球客户及合作伙伴共同达成，在Medidata平台和生命科学解决方案支持下，赋能更智能的治疗方案，让更多患者获益，同时也推动更多试验的成功。...
View ArticleClik here to view.
为了向全世界宣传纳豆的魅力，日本纳豆合作社联合会于3月6日（星期一）推出中文版官方网站“Natto Power——日本发酵食品纳豆，改善生活的关键”
东京 (美国商业资讯)–日本纳豆合作社联合会（东京荒川区；会长：野吕义弘）推出中文版新网站“Natto Power——日本发酵食品纳豆，改善生活的关键”，旨在宣传纳豆的魅力，将这种有助于日本人民健康的日本传统食品推向全世界。 •“Natto Power”中文版官方网站网址 https://www.natto-power.com/cn/...
View ArticleClik here to view.
Prestige Biopharma Develops First-in-Class PAUF-detecting Diagnostic Kit, a...
SINGAPORE Prestige Biopharma Limited, a Singapore-based biopharmaceutical company, has developed a first-in-class diagnostic kit for pancreatic cancer. Pancreatic cancer is a characteristically...
View ArticleClik here to view.
オルガノンが計画外妊娠の削減というニーズが高く格差のある問題で新たな世界的イニシアチブ「Her Plan is Her Power」を発足
米ニュージャージー州ジャージーシティ （ビジネスワイヤ） — 女性の健康増進に傾注する世界的ヘルスケア企業のオルガノン（NYSE：OGN）は本日、新たな世界的イニシアチブ「Her Plan is Her...
View ArticleClik here to view.
Organon新推出“她的计划就是她的力量”全球倡议，旨在减少意外怀孕，满足大量的女性避孕需求，弥合不同地区之间的差距
新泽西州泽西市 (美国商业资讯)–专注于改善女性健康的全球医疗保健公司Organon (NYSE: OGN)今天宣布启动新的全球倡议“她的计划就是她的力量”(Her Plan is Her Power)，以加速推动解决意外怀孕这一公共健康危机。据估计，全世界每年有近50%的怀孕（约1.21亿例）属于意外怀孕，导致母亲和孩子的健康风险以及女性受教育和就业机会减少，而这些挑战可能会影响几代人。...
View ArticleClik here to view.
欧洲麻醉学和重症监护学会(ESAIC)推荐无创连续血红蛋白监测
瑞士纳沙泰尔 (美国商业资讯)–Masimo (NASDAQ: MASI)今天宣布，欧洲麻醉学和重症监护学会(ESAIC)发布的最新指南强调了无创的连续血红蛋白(Hb)监测在指导临床医生管理围手术期出血方面的价值。该指南参考了采用Masimo SpHb®等技术的临床研究，指出“使用无创Hb监测方法可能是一种连续监测Hb浓度且不会造成额外累积失血的实用方法。”1...
View ArticleClik here to view.
HPO, in Collaboration with Eastman, Announces Upcoming Launch of High Energy...
CHARLOTTE, N.C. Eastman and High Performance Optics, Inc. (HPO) announced today that a selective High Energy Visible Light (HEVL) filtering window film for the transportation industry will be...
View ArticleClik here to view.
欧州麻酔・集中治療学会（ESAIC）が非侵襲的・連続的ヘモグロビンモニタリングを推奨
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、欧州麻酔・集中治療学会（ESAIC）が発表した最新のガイドラインで、医師による周術期の出血管理を支える上で、非侵襲的・連続的ヘモグロビン（Hb）モニタリングが持つ価値が強調されていると発表しました。ガイドラインは、Masimo...
View ArticleClik here to view.
BIO KOREA 2023: Registration Now Open for Business Partnering
SEOUL, South Korea The Korea Health Industry Development Institute (KHIDI, President: Cha Soon-do) and Chungcheongbuk-do (Governor: Kim Young-hwan) invite companies to participate in the Business...
View ArticleClik here to view.
Theramex Enters Into an Exclusive Licensing Agreement With Radius Health Inc,...
LONDON Theramex, a leading global speciality pharmaceutical company dedicated to women’s health, has entered into an exclusive licensing agreement with Radius Health, Inc., for the rights to...
View ArticleClik here to view.
Prestige Biopharma Receives FDA Fast Track Designation for PBP1510 in the...
SINGAPORE Prestige Biopharma has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for PBP1510 (International Non-proprietary name: Ulenistamab), in the treatment of...
View ArticleClik here to view.
Alveo Technologies Announces ISO 13485:2016 Certification
ALAMEDA, Calif. Alveo Technologies, Inc. (Alveo), a leader in molecular sensing and diagnostics with its proprietary be.well™ technology platform, today announced its quality management system (QMS)...
View ArticleClik here to view.
AHF: It’s China’s Turn to Declassify COVID data
LOS ANGELES President Biden signed into law yesterday a bill requiring the declassification of as much information as possible related to the origins of COVID-19. AIDS Healthcare Foundation (AHF)...
View ArticleClik here to view.
‘Medical Korea 2023 Conference’ on Global Medical Industry Prospects to Kick...
SEOUL, South Korea The Ministry of Health and Welfare (MOHW) and the Korea Health Industry Development Institute (KHIDI) will host Medical Korea 2023 – The 13th Global Healthcare & Medical...
View ArticleClik here to view.
关注全球医疗行业前景——“Medical Korea 2023”会议将于3月23日在首尔Coex会展中心拉开帷幕
韩国首尔 (美国商业资讯)–韩国卫生福利部(MOHW)和韩国健康产业发展研究院 (KHIDI)将于2023年3月23日（周四）至3月24日（周五）在首尔Coex会展中心举办“Medical Korea 2023”暨第13届全球保健与医疗旅游大会。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
何塞-巴塞尔加研究基金宣布首次为推进朊病毒病研究拨款
波士顿 (美国商业资讯)–Alexion是阿斯利康旗下的罕见病公司。该公司支持的何塞-巴塞尔加研究基金(JBRF)今天宣布启动全球何塞-巴塞尔加研究资助项目(Baselga Grant)。该基金每年将拨款7.5万美元，用于推动朊病毒疾病的疗法。朊病毒疾病是一组罕见的进行性神经变性疾病。 JBRF由巴塞尔加家族为纪念何塞-巴塞尔加(José...
View ArticleClik here to view.
Wishcompany’s Meditation Content ‘Mind Nook’ Surpasses 1M Subscribers
SEOUL, South Korea Global beauty company Wishcompany (CEO Park Soung-ho) announced that its mental wellness brand ‘Mind Nook’ content gained popularity and surpassed a million subscribers. With over...
View ArticleClik here to view.
ホセ・バセルガ研究基金がプリオン病研究を前進させるための初の助成を発表
ボストン （ビジネスワイヤ） — アレクシオン・アストラゼネカ・レアディジーズの支援を受けるホセ・バセルガ研究基金（JBRF）は本日、希少な進行性神経変性疾患群であるプリオン病の治療を前進させるために毎年7万5000ドルを助成する「世界ホセ・バセルガ研究助成金（バセルガ助成金）」の創設を発表しました。...
View ArticleClik here to view.
Norges Bank Terminates Its Observation On Kirin Holdings
TOKYO Kirin Holdings Company, Limited (Kirin Holdings)(TOKYO:2503) today announces that Norges Bank has terminated its observation on Kirin Holdings on March 22 2023, recognizing the completion of...
View ArticleClik here to view.
Incyte Announces Japanese Approval of Pemazyre® (pemigatinib) for the...
WILMINGTON, Del. & TOKYO Incyte (Nasdaq:INCY) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Pemazyre® (pemigatinib), a selective fibroblast growth...
View Article